Estimates Revisions Devyser Diagnostics AB Börse Stuttgart
Stocks
OL0
SE0016588867
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.890 EUR | +5.18% |
|
+5.75% | -42.37% |
| 08:45am | Devyser CEO Jan Wahlström buys shares for just over SEK 0.3m | FW |
| 07-21 | Pareto Securities cuts Devyser target price to 90 kronor (140), reiterates buy | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DVYSR Stock
- OL0 Stock
- Consensus Devyser Diagnostics AB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
